1  significant familial aggregation of primary Raynaud's disease.

2           Twenty-three patients with primary Raynaud's disease and their first-degree relatives were

3 enia, hypothyroidism, inflammatory myositis, Raynaud's disease and vitiligo.

4 SSc, all of whom experienced their first non-Raynaud's disease-associated disease manifestation withi

5 ed flares are normal, and those with primary Raynaud's disease, in whom the ET-1 flare is reduced and

6 agonists and cooling associated with primary Raynaud's disease (RD).

7                                              Raynaud's disease severity and duration of lcSSc were li

8 e regression including age demonstrated that Raynaud's disease severity could predict a reduction in

9 itis (PM/DM), and a random selection of SSc, Raynaud's disease, systemic lupus erythematosus, and rhe

10 ation predicted by TDS, age, and severity of Raynaud's disease VAS.

11                                              Raynaud's disease visual analog scale (VAS) scores, lung

12                            The prevalence of Raynaud's disease was significantly higher in the famili